Novartis Signs a Multiyear Agreement with Microsoft to Transform Medicine with the Launch of AI Innovation Lab
Shots:
- Novartis to launch AI innovation lab with Microsoft as its strategic AI and data-science partner to transform the discovery- development & commercialization of medicines by leveraging AI & data intelligence
- The strategic alliance will collaborate Novartis’ life sciences expertise with the power of Azure and Microsoft AI with the two main objectives i.e- AI Empowerment & AI Exploration
- The multi-year research and development agreement will involve joint research activities at Novartis Campus (Switzerland)- at Novartis Global Service Center in Dublin- and at Microsoft Research Lab (UK) initiating with personalized therapies for macular degeneration- cell & gene therapy and drug design
Click here to read full press release/ article | Ref: Microsoft | Image: Windows Central
This content piece was prepared by our former Senior Editor. She had expertise in life science research and was an avid reader. For any query reach out to us at connect@pharmashots.com